Why Tuesday Morning Shares Are Trading Lower By 38%; Here Are 31 Stocks Moving Premarket
Gainers
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 106.9% to $0.5482 in pre-market trading on heavy volume.
Soligenix To Receive $1.2M In Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program
Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced
Soligenix Invited To Submit BARDA Contract Proposal For Development Of Thermostabilized Subunit Vaccines For Sudan Ebola And Marburg Viruses
Emerging infectious diseases where no protective vaccines are currently available
SuVax™ targets Sudan ebolavirus, origin of a current disease outbreak in Uganda
11 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers
Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 30.46% to $0.59. The market value of their outstanding shares is at $53.5 million.
Soligenix Announces FDA Awards $2.6M Orphan Products Development Grant For Expanded Study Of HyBryte In The Treatment Of Cutaneous T-Cell Lymphoma
Grant supports study of expanded HyBryte™ treatment, including in the Home Use Setting
PRINCETON, N.J., Sept. 6, 2022 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage
SNGX: Receives IND Clearance for Phase 2 Clinical Trial in Psoriasis…
By David Bautz, PhD
NASDAQ:SNGX
READ THE FULL SNGX RESEARCH REPORT
Soligenix Receives Agreement From FDA On Initial Pediatric Study Plan For HyBryte For The Treatment Of Cutaneous T-Cell Lymphoma
Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced
Soligenix Partners With SERB Pharmaceuticals To Supply Ricin Antigen For Ricin Toxin Poisoning Treatment
Soligenix Inc (NASDAQ:SNGX) has signed a worldwide license to supply its ricin antigen to SERB Pharmaceuticals for novel therapeutic treatment against…